Jasper Therapeutics Inc. (JSPRW) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Jasper Therapeutics Inc.

NASDAQ: JSPRW · Real-Time Price · USD
0.09
-0.01 (-14.29%)
At close: Jun 09, 2025, 3:57 PM

Jasper Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
71.64M 86.89M 38.25M 84.7M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 417K 345K
Other Long-Term Assets
1.24M 1.76M 1.18M 990K
Receivables
n/a 250K n/a n/a
Inventory
n/a n/a n/a -548K
Other Current Assets
646K 309K 1.87M 837K
Total Current Assets
75.81M 88.94M 41.73M 87.83M
Property-Plant & Equipment
2.85M 4.19M 5.45M 4.83M
Goodwill & Intangibles
n/a n/a -980K -668K
Total Long-Term Assets
4.09M 5.95M 6.63M 5.82M
Total Assets
79.9M 94.89M 48.36M 93.65M
Account Payables
4.03M 4.15M 1.77M 3.92M
Deferred Revenue
n/a n/a n/a 2.81M
Short-Term Debt
1.09M n/a 865K 505K
Other Current Liabilities
3.7M 5.49M 1.98M 1.43M
Total Current Liabilities
15.24M 12.37M 7.07M 8.02M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
2.26M 2.26M 2.52M 13.74M
Total Long-Term Liabilities
2.99M 4.08M 5.31M 16.12M
Total Liabilities
18.23M 16.45M 12.37M 24.14M
Total Debt
1.81M 2.79M 3.65M 2.88M
Common Stock
2K 1K 4K 4K
Retained Earnings
-240.87M -169.6M -105.14M -67.45M
Comprehensive Income
n/a n/a 0.00 -93.65M
Shareholders Equity
61.67M 78.44M 35.99M 69.52M
Total Investments
n/a 417K 417K 345K